title: Re: Yves Allorya, Willemien Beukers, Ana Sagrera, et al. Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur Urol 2014;65:360-6: telomerase expression and stem cells: urologic epithelial perspective.
authors.affiliation: YCR Cancer Research Unit, Department of Biology, University of York, York, UK.
authors.forename: Jayant K
authors.initials: JK
authors.lastname: Rane
authors.affiliation: Department of Urology, Castle Hill Hospital, Cottingham, UK; Hull York Medical School, University of Hull, Hull, UK.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Simms
authors.affiliation: YCR Cancer Research Unit, Department of Biology, University of York, York, UK; Hull York Medical School, University of Hull, Hull, UK. Electronic address: n.j.maitland@york.ac.uk.
authors.forename: Norman J
authors.initials: NJ
authors.lastname: Maitland
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D011401:Promoter Regions, Genetic; D019098:Telomerase / Q000235:genetics*; D001749:Urinary Bladder Neoplasms / Q000201:enzymology* / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D019098:Telomerase